AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
"Osteoarthritis is associated with increased bone resorption and increased cartilage degradation in the subchondral bone and joint. The objective of the present study was to determine whether Tibolone, a synthetic steroid with estrogenic, androgenic, and progestogenic properties, would have similar dual actions on both bone and cartilage turnover, as reported previously with some SERMS and HRT," scientists writing in the journal BMC Musculoskeletal Disorders report (see also Bone Research).
"This study was a secondary analysis of ninety-one healthy postmenopausal women aged 52-75 yrs entered a 2-yr double blind, randomized, placebo-controlled study of treatment with either 1.25 mg/day (n = 36), or 2.5 mg/day Tibolone ( n = 35), or placebo ( n = 20), (J Clin Endocrinol Metab. 1996 Jul; 81(7):2419-22) Second void morning urine samples were collected at baseline, and at 3, 6, 12, and 24 months. Urine CrossLaps (R) ELISA (CTX-I) and Urine CartiLaps (R) ELISA (CTX-II) was investigated as markers of bone resorption and cartilage degradation, respectively. Tibolone significantly (P
The researchers concluded: "These effects may in part be described by the complicated pharmacology of Tibolone on testosterone, estrogen and progesterone receptors."
Karsdal and colleagues ...